COVID-19

Inhibiting an enzyme variant that contributes to severe COVID-19 in men holds promise for treating SARS-CoV-2 infections. 

Katalin Karikó and Drew Weissman received this year’s Physiology or Medicine award for their work on RNA biology and mRNA-based vaccines.

Robert Georgantas aims to expand the development of mRNA-based vaccines for a range of infectious diseases and cancers.

Researchers discovered how SARS-CoV-2 invades and spreads through nasal epithelial cells, identifying potential new drug targets to prevent transmission.

The success of vaccines and cancer treatments varies depending on the time of day they are delivered. Researchers now look to exploit circadian rhythms to improve health outcomes.

In writing about new pain treatments that could benefit a family member, I was reminded of the real people behind every study and story.

Using optogenetics, neurobiologists traced a stimulating physical touch from the skin all the way to the reward center of the brain for the first time.

As scientific conferences return to in person programming, we still need COVID-19 precautions.

Microarray, or microneedle, patches could boost vaccine access in low- and middle-income countries.

What do zoonotic spillover events reveal about virus-host biology and how do scientists use these lessons to inform future mitigation strategies?